PSA testing: When it's useful, when it's not
Metadata[+] Show full item record
Do not routinely screen all men over the age of 50 for prostate cancer with the prostate-specific antigen (PSA) test. Consider screening men younger than 75 with no cardiovascular or cancer risk factors -- the only patient population for whom PSA testing appears to provide even a small benefit. Stength of recommendation: B: Based on a meta-analysis of 6 randomized controlled trials (RCTs) with methodological limitations, and a post hoc analysis of a large RCT.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.